Office of Technology Development presents a third opportunity to engage with industry
(for more information go to http://www.ou.edu/otd/ICO, or email firstname.lastname@example.org for specific submission details):
Almirall is looking to sponsor academic research for target identification, validation, and/or to advance
pre-clinical therapeutic opportunities into clinical settings for “novel targets, pathways, or therapeutic
candidates relating to chronic immune-inflammatory disease” (expiration 9/30/19). Funding up to $250K
per project to be awarded by Almirall in November 2019.
Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS
The abstract submission deadline for the HHDC 2019 Research Symposium is Friday, October 4th.
Abstracts must be received by 5 p.m. HHDC 2019 Research Symposium will be held on Friday, November
15, 2019 at the Samis Education Center in Children’s Hospital in Oklahoma City. The Symposium will
consist of selected oral presentations, a poster session, and Symposia talks by P. Darrell Neufer, PhD,
Professor, East Carolina University, Matthew Rodeheffer PhD, Associate Professor, Yale University and
Scott Summers, PhD, Professor and Chair, The University of Utah. For abstract submission guidelines
and to RSVP for this free event, please go to:
Please contact Katie-Hoefling@ouhsc.edu with any questions for this event.
OUHSC researchers, you may find this press release of interest:
The release describes the federal charges filed this week against a faculty researcher at the University of Kansas.
The researcher neglected to disclose his appointments at other institutions on his federal grant applications, as required
by the granting agencies, and to the university, as required by the KU conflicts of interest policy.
Disclosures of potential conflicts of interest, such as support from or appointments at other institutions, are required by
federal funding agencies (see, for example, https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-114.html) and
by OU’s Conflicts of Interest policy. The linked documents are good reminders to all researchers who receive federal
funds to ensure their disclosures of potential conflicts of interest are complete and accurate for each grant submission
and renewal. I strongly encourage you to review the grant applications you have submitted for your current grants and
ensure you have fully disclosed any conflicts, including appointments at other institutions – both U.S. and foreign – to
the granting agency and to the University. If you have questions about reporting conflicts to the University, please
contact Martha Ogilvie at Marthaemail@example.com. For assistance with grants, please contact your Sponsored
Program Administrator in the Office of Research Administration at firstname.lastname@example.org.
IMPORTANT NIH INFORMATION: ORCID Number – an ORCID Number is required of all Individuals Supported
by Research Training, Fellowship, Research Education, and Career Development Awards Beginning in FY 2020. This
requirement will go into effect October 1, 2020. For the specific Notice and instructions on how to get your assigned
ORCID Number please go to: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-109.html
The University of Oklahoma Center on Native Health Center of Biomedical Research Excellence
(COBRE) on the Norman campus is requesting preproposals to advance inquiry into the social and behavioral
determinants of the health of American Indian people in Oklahoma. Interested candidates should submit a one-page
overview (including specific aims) of their proposed research as a PDF file to Paul Spicer (email@example.com) no
later than September 15, 2019. Project budgets generally will not exceed $150,000 in direct costs for each year.
For additional information refer to the attached document.
https://research.ouhsc.edu/Portals/1329/Assets/Documents/OUCNH Call for Proposals 190821.docx?ver=2019-08-26-082925-747
Save the Date – ORA Noon Conference
Navigating the ORA Proposal Submission Process
Speaker(s): Caitlin Novotny, MBA, CRA, Sponsored Programs Administrator II, Office of Research Administration
Offered: September 25, 2019 LIB-299 12-1pm
Overview: This session will cover the basics of proposal preparation and map out the process of submission
through the Office of Research Administration. We will discuss what your Sponsored Programs Administrator looks for
during the pre-award review, such as budget considerations, eligibility, and compliance with applicable rules and policies.
We will also cover topics related to proposal submission, such as grant routing forms and the systems used to submit
federal grants. The overall goal of this presentation is to provide a basic understanding of and advice on proposal
preparation and submission
National Cancer Institute Predoctoral to Post-Doctoral Fellow Transition Award (F99/K00)
OUHSC can nominate one graduate student in their 3rd or 4th year since beginning graduate school who is
working towards their PhD degree to apply for an F99/K00 award from the NCI
(https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-057.html). Note: Dual-degree, or professional doctorate/
clinical degree students are not eligible.
- Purpose: The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to
encourage and retain outstanding graduate students recognized by their institutions for their high potential
and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the
transition of talented graduate students into successful cancer research postdoctoral appointments, and
provide opportunities for career development activities relevant to their long-term career goals of becoming
independent cancer researchers. Final F99/K00 application due date at NIH is December 4th.
- Eligibility: 3rd or 4th year graduate student working on a specific cancer-related Ph.D. dissertation project
that wants to transition in the next 1-2 years to a postdoctoral fellowship research in cancer research.
- Submitting a pre-proposal: A pre-proposal must be submitted to the Graduate College by September 6, 2019.
Pre-proposals must include:
- Specific Aims Page: there are 2 required Specific Aims as follow:
- Aim 1: The Dissertation Research Project
- Aim 2: The Postdoctoral Research Direction
- Letter of support from F99 sponsor(s)
- Full CV of applicant including academic record and prior research experience
- NIH Biosketch of sponsor(s)
- Submit the pre-proposal as a single file in PDF format to: Gillian-Air@ouhsc.edu in the Graduate College
- Pre-proposals will be reviewed by a panel of expert cancer researchers and educators.
- Questions: contact Darrinfirstname.lastname@example.org or Gillianemail@example.com
DEADLINE UPDATE: IBEST-OUHSC Funding for Interdisciplinary Research – Request for Applications to support
collaborative research activities between OUHSC researchers and OU-Norman researchers in the area of biomedical engineering
Deadline September 6, 2019 – please see guidelines and face page attached
NIH Announces New Centralized Notifications for Unfunded Applications (NOT-OD-19-133)
Clarifying Competing Application Instructions and Notice of Publication of Frequently Asked Questions (FAQs) Regarding
Proposed Human Fetal Tissue Research (NOT-OD-19-137)
Notice of Informational Webinar on the NIH Maximizing Opportunities for Scientific and Academic Independent Careers
(MOSAIC) Program Funding Opportunity Announcements (UE5 and K99/R00)
Request for Information (RFI): Strategies to Support Acquisition and Use of Biospecimens for Research on Sepsis in
Notice of NIAAA's Participation in PAR-19-162 "Accelerating the Pace of Child Health Research Using Existing Data
from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)” (NOT-AA-19-023)
Notice of NIAAA's Participation in PAR-19-163 "Accelerating the Pace of Child Health Research Using Existing Data
from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)" (NOT-AA-19-024)
Notice to Extend the Expiration Date for PAR-18-644 "Advanced-Stage Development and Utilization of Research
Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional)" (NOT-AG-19-038)
Notice to Extend the Expiration Date for PAR-18-645 "Research Infrastructure Development for Interdisciplinary Aging
Studies (R21/R33 - Clinical Trial Optional)" (NOT-AG-19-039)
Notice of FY2020 Cohort Dates for PA-19-029, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational
Research (Admin Supp Clinical Trial Not Allowed) (NOT-CA-19-067)
Notice to Extend PAR-18-727, Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary
Exposure (R01 Clinical Trial Optional) (NOT-DK-19-018)
Notice of Increased Budget Limits and NINDS Participation in PAS-19-317 "Advancing Research on Alzheimer's Disease
(AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)" (NOT-NS-20-001)
Notice to Extend the Expiration Date for PA-18-141 "Mechanisms, Models, Measurement, & Management in Pain Research
(R01 Clinical Trial Optional)" (NOT-NS-20-003)
Notice to Extend the Expiration Date for PA-18-159 "Mechanisms, Models, Measurement, & Management in Pain Research
(R21 Clinical Trial Optional)" (NOT-NS-20-004)
Please Note: When only one application is allowed per Institution according to the sponsor
instructions, a one-page letter of intent summarizing the proposed project should be submitted
to the Vice President for Research at least one month prior to the application deadline (unless
otherwise noted). The letters of intent will be reviewed and a single application will be chosen
for submission from the University.
Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients
(R21 Clinical Trial Not Allowed) (PAR-19-351) – Deadline October 16,2019 and February 16, 2020